Developer of universal vaccines designed to prevent globally impactful infectious diseases, starting with influenza. The company leverages its technology and acts as a universal vaccine against all ex...

Healthcare
Lyon, France
Founded 2017
50 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$45.4M
Last Round
N/A

Get the full picture

Create a free account to unlock Osivax's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required